Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Be Given Cost-Effectiveness Role, Acting Commissioner Predicts

Executive Summary

Congress is likely to consider expanding FDA's mission to include direct consideration of economic factors in making approval decisions, Acting Commissioner Lester Crawford, PhD, predicted

You may also be interested in...



FDA Personnel Moves Signal Continuity Under Commissioner Crawford

Five top-level FDA personnel appointments implemented July 29 suggest general agency policy will likely go unchanged in the near future

FDA Personnel Moves Signal Continuity Under Commissioner Crawford

Five top-level FDA personnel appointments implemented July 29 suggest general agency policy will likely go unchanged in the near future

Breakthrough Drug Prices Will Be “Huge” Policy Issue; IoM Plans Forum

The next frontier in the debate over drug pricing will be the cost of highly effective breakthrough drugs, CMS Chief Medical Officer Sean Tunis, MD, predicted during the Biotechnology Industry Organization annual meeting in San Francisco June 7

Related Content

UsernamePublicRestriction

Register

PS043670

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel